What does NABP consider hazardous drug compounding?
For purposes of NABP’s inspection and accreditation programs, we consider the pharmacy to be compounding a hazardous drug when the drug is listed on either Table 1 or Table 2 of the current NIOSH list (or meets the requirements to be placed onto the NIOSH list) and the pharmacy is manipulating the drug consistent with the definition of “compounding.”
As long as the pharmacy is only counting, pouring, or repackaging a hazardous drug that is already in a final dosage form, the pharmacy would not be required to complete the hazardous drug compounding (USP <800>) module. If the pharmacy compounds a single hazardous drug, the hazardous drug compounding module is required.
For example, if the pharmacy dispenses methotrexate oral tablets from a manufacturer’s container into a patient-specific prescription container, that would be considered “counting.”